The landscape of biosecurity risks related to AI is complex and rapidly changing, and understanding the range of issues requires diverse perspectives and expertise. Here are five promising ideas that match the diversity of challenges that AI poses in the life sciences.
Excited delirium, a diagnosis generally characterized by a severely agitated state, made headlines in some of the most contentious deaths in custody.
Common frameworks for evaluating proposals leave this utility function implicit, often evaluating aspects of risk, uncertainty, and potential value independently and qualitatively.
As Congress moves forward with the appropriations process, both the House and Senate have proposed various provisions related to artificial intelligence (AI) and machine learning (ML) across different spending bills.
The looming competition for global talent has brought forth a necessity to evaluate and update the policies concerning international visa holders in the United States.
Researchers at the nonpartisan science think tank support Biden’s executive order on the use of artificial intelligence in government.
Successful commercialization efforts have now grown across the country, but what do they have in common, and why do they work? Our experts weigh in.
The future of industrial growth resides in the establishment of biotechnology as a new pillar of industrial domestic manufacturing. Here’s how BioNETWORK will advance domestic biomanufacturing.
Responsible governance is crucial to harnessing the immense benefit promised by AI. Here are recommendations for advancing ethical, high-impact AI with thoughtful oversight.
September should be bioeconomy month. To celebrate, we took our experts to the Hill to share their research and recommendations with Congress.
Despite growing international competition, appropriations for research agencies have fallen quite short of the CHIPS and Science targets.
The U.S. federal government is the largest funder of scientific research in the world — but it is risk-averse to a fault. New approaches to peer review can bring American research back to the bleeding edge.